Instil Bio (TIL) Free Cash Flow (2020 - 2026)
Instil Bio (TIL) posted quarterly Free Cash Flow of -$1.3 million for Q1 2026, up 69.45% year-over-year from -$741797.6 in Q1 2025, and up 82.03% quarter-over-quarter from -$7.0 million in Q4 2025.
Instil Bio (TIL) Free Cash Flow (2020 - 2026) Analysis & Trends
Instil Bio's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 69.45% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$33.3 million (up 32.77% YoY), while the FY2025 annual figure was -$36.2 million, up 39.74% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.3 million, up from -$7.0 million in the prior quarter.
- The five-year high for Free Cash Flow was -$1.3 million in Q1 2026, with the low at -$65.5 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$17.3 million (2025), against an average of -$23.1 million.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 246.36% in 2022, then soared 75.88% in 2023.
- Instil Bio's Free Cash Flow stood at -$34.4 million in 2022, then advanced by 0.17% to -$34.3 million in 2023, then surged by 65.6% to -$11.8 million in 2024, then jumped by 40.75% to -$7.0 million in 2025, then jumped by 82.03% to -$1.3 million in 2026.
- Business Quant data shows TIL's Free Cash Flow at -$1.3 million in Q1 2026, -$7.0 million in Q4 2025, and -$7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | -4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.56 Mn |
| Jun 30, 2026 | -4.56 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | -7.00 Mn |
| Dec 31, 2025 | -7.00 Mn |
| Sep 30, 2025 | -7.77 Mn |
| Sep 30, 2025 | -7.77 Mn |
| Jun 30, 2025 | -17.31 Mn |
| Jun 30, 2025 | -17.31 Mn |
| Mar 31, 2025 | -4.12 Mn |
| Mar 31, 2025 | -4.12 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -22.35 Mn |
| Sep 30, 2024 | -22.35 Mn |
| Jun 30, 2024 | -11.32 Mn |
| Jun 30, 2024 | -11.32 Mn |
| Mar 31, 2024 | -14.59 Mn |
| Mar 31, 2024 | -14.59 Mn |